Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Judy Harvey-White"'
Autor:
Reiner Jumpertz, Tobias Wiesner, Pal Pacher, Sandor Batkai, Jens Jordan, Matthias Blüher, George Kunos, Judy Harvey-White, Hubertus Wirtz, Stefan Engeli, Andrea Bosse-Henck, Michael Stumvoll
Publikováno v:
Journal of Hypertension. 30:2345-2351
Objective: Obstructive sleep apnea chronically increases blood pressure through sympathetic nervous system activation. In animals, hypertension and sympathetic activity are restrained by cannabinoid receptor activation. Therefore, we hypothesized tha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8dcf24f1e987bfdc4e8bb6771dedc194
https://doi.org/10.1097/hjh.0b013e3283591595
https://doi.org/10.1097/hjh.0b013e3283591595
Publikováno v:
International Journal of Obesity. 30:S33-S38
The endocannabinoid system has recently emerged as an important regulator of energy homeostasis, involved in the control of both appetite and peripheral fat metabolism. We briefly review current understanding of the possible sites of action and cellu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::112e29e3584602d6bcfa0bae3d7e13f0
https://doi.org/10.1038/sj.ijo.0803276
https://doi.org/10.1038/sj.ijo.0803276
Autor:
Pal Pacher, Attila Brassai, George Kunos, Sandor Batkai, László Offertáler, Jie Liu, Judy Harvey-White, Benjamin F. Cravatt, Zoltán Járai, Douglas Osei-Hyiaman
Publikováno v:
American Journal of Physiology-Heart and Circulatory Physiology. 289:H533-H541
The endocannabinoid anandamide exerts neurobehavioral, cardiovascular, and immune-regulatory effects through cannabinoid receptors (CB). Fatty acid amide hydrolase (FAAH) is an enzyme responsible for the in vivo degradation of anandamide. Recent expe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2556900be8f2bccd2e184761a0200f60
https://doi.org/10.1152/ajpheart.00107.2005
https://doi.org/10.1152/ajpheart.00107.2005
Autor:
Stefan Engeli, Judy Harvey-White, Jana Böhnke, Mareike Feldpausch, K. Gorzelniak, Sandor Batkai, Friedrich C. Luft, Pal Pacher, Jens Jordan, Arya M. Sharma, Jürgen Janke
Publikováno v:
Diabetes. 54(10)
Obesity is the main risk factor for the development of type 2 diabetes. Activation of the central endocannabinoid system increases food intake and promotes weight gain. Blockade of the cannabinoid type 1 (CB-1) receptor reduces body weight in animals
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4c4f2d90705ad4ff5214bb0dd4b78e3
https://pubmed.ncbi.nlm.nih.gov/16186383
https://pubmed.ncbi.nlm.nih.gov/16186383